Navigation Links
GlaxoSmithKline Responds to JAMA Articles
Date:9/11/2007

PHILADELPHIA, Sept. 11 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) believes that conclusions drawn from the most recent meta-analyses published by Drs. Nissen et. al. and Furberg et. al. in the Journal of the American Medical Association (JAMA) do not confirm a difference in the safety profile of Avandia(R) (rosiglitazone) and Actos(R) (pioglitazone). These analyses reflect limitations that are common to all meta-analyses, by the authors' own admission. These analyses do not yield data robust enough to guide doctors in selecting appropriate diabetes treatments for their patients. Comparisons between different meta-analyses with different endpoints and patient populations are even more unreliable.

The Actos meta-analysis is based on a small number of studies (19) provided directly by Takeda, and is heavily biased by data from the PROactive study (5,238 patients) which contributed 80 percent of the endpoint data. The patient population in the PROactive study was at high risk of cardiovascular disease.

-- PROactive compared diabetic patients on Actos to those on placebo.

Patients taking Actos to control blood sugar might be expected to have

fewer cardiovascular events than those who were not controlled on

medication, consistent with the primary results of PROactive (Hazard

Ratio 0.90 p=0.095). However, as described by FDA in the recent

Advisory Committee, at six months PROactive actually showed an

increased risk of heart attack (HR 1.2).

-- Applying the endpoint of CV death, myocardial infarction and stroke to

the data on Avandia across long-term clinical trials to enable a closer

like-for-like comparison with the Actos meta-analysis shows no

statistical difference between Avandia and comparators (a hazard ratio

of 1.03). In RECORD, a study specifically designed to look at

cardiovascular events, no real difference was seen between Avan
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
2. GlaxoSmithKline To Cultivate Non-Smoking Environment
3. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
4. FDA Mislead On Asthma Drug By GlaxoSmithKline
5. GlaxoSmithKline Defends Its Products
6. GlaxoSmithKline launches diabetes and cancer drugs
7. Generic Products Compete With GlaxoSmithKline
8. GlaxoSmithKline Agrees To Settle Paxil Claims For $14 million
9. GlaxoSmithKlines Zofran Helps In Treatment Of Dehydration In Children
10. Ranbaxy Acquires Glaxosmithklines Generic Unit in Spain
11. GlaxoSmithKline’s Epilepsy Drug given the Green Signal by FD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... poor printing on prescription labels handed out by ... errors in taking medication, according to new research ... National Institute for the Blind)., The study, published ... found that labels on prescription medications dispensed by ... for legibility. , By simply following recommended guidelines ...
(Date:7/9/2014)... , , , , , ... , , , ... weapon was an SA80 assault rifle and the microphone is 50m downrange from the firer and approximately 30cm from the bullet... , ... , , , , ... , , , , ...
(Date:7/9/2014)... allergic diseases has risen dramatically in Western societies. One ... to microorganisms and have fewer infections than previous generations, ... study by researchers at Sahlgrenska Academy, University of Gothenburg, ... maturation of the immune system in relation to allergic ... of the Vstra Gtaland Region, half of them on ...
(Date:7/8/2014)... Older kidney donors enjoy similar longevity and cardiovascular health ... study published in the American Journal of Transplantation ... individuals considering donation and the transplant professionals caring for ... donation by individuals aged 55 years and older has ... kidney disease, and heart disease, the removal of a ...
(Date:7/8/2014)... Defense Advanced Research Projects Agency (DARPA) awarded Lawrence ... to develop an implantable neural device with the ... brain to help restore memory, DARPA officials announced ... understanding that memory is a process in which ... information, store it and retrieve it. Certain types ...
Breaking Medicine News(10 mins):Health News:Most prescription labels fail to meet guidelines, risking dosage errors 2Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 2Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 3Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 4Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 5Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 6Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 7Health News:Study finds kidney donation safe for healthy older adults 2Health News:DARPA selects Lawrence Livermore to develop world's first neural device to restore memory 2Health News:DARPA selects Lawrence Livermore to develop world's first neural device to restore memory 3
... -- Increasing the availability of public transit systems is ... environment that offers opportunities for increasing physical activity and ... In a study published in the August issue of ... from the University of Pennsylvania, Drexel University and the ...
... ... announces the release of their latest offering to the Life Sciences, University, and Clinical ... microbiology & cell biology applications. , ... (PRWEB) June 29, 2010 -- Anaerobic Glove Boxes have made ...
... ... a California based laboratory equipment repair and instrument calibration services company, has been ... accredited calibration lab., , ... (PRWEB) June 29, 2010 -- Beginning in 2009, the AL-TAR ...
... ... has dedicated his life to educate and inform the world on the benefits of ... , ... 2010 -- World-renowned health educator and clinical nutritionist, Byron J. Richards, celebrated the 100th ...
... ... design agency e-Moonlighting.com has launched a free Marketing Help section on its ... new concept. A marketing and design agency which provides effective marketing, website ... traditional offline agency. The agency has a unique, virtual, low cost structure ...
... ... have been taken off the U.S. market, forcing countless patients to find an equivalent medication. ... frustrations, and have found that they are not alone with their struggle. Learn more about ... ...
Cached Medicine News:Health News:Public transit systems contribute to weight loss and improved health 2Health News:Sheldon Manufacturing, Inc. Announces New Ergonomic Bactron Anaerobic Chamber For Microbiology Research 2Health News:AL-TAR Services, Inc. Laboratory Is Now Accredited For ACLASS Standards 2Health News:Health Podcast by World-Renowned Health Educator Celebrates 100th Episode and Continues to Offer Life-Changing Advice 2Health News:Marketing Help from e-Moonlighting.com 2Health News:Impact of Azmacort Withdrawal Brought to Light in Medicine Community 2Health News:Impact of Azmacort Withdrawal Brought to Light in Medicine Community 3Health News:Impact of Azmacort Withdrawal Brought to Light in Medicine Community 4Health News:Impact of Azmacort Withdrawal Brought to Light in Medicine Community 5
(Date:1/14/2014)... HILLS, Calif. , Jan. 14, 2014 The Brandeis Medical ... Los Angeles a premier and affordable laser tattoo removal ... special. Dr. Brandeis, focus is in providing high quality cosmetic services ... all patients. " Southern California has ...
(Date:1/14/2014)... , Jan. 14, 2014 Animal Emergency Critical Care, a LifeCentre ... Leesburg, Virginia is the first in Loudoun ... Dr. Susan M. Barnes , Medical Director, ... and husband, Dr. Cole Taylor , are avid scuba divers. ...
(Date:1/14/2014)...   Oligomerix, Inc. , a privately held company pioneering ... (AD) and related neurodegenerative disorders, announced today the relocation ... as of January 15, 2014 and expanded ... Medical College. Oligomerix, which is focused on ...
Breaking Medicine Technology:Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... Prolong Pharmaceuticals today announced that industry veteran Glenn Kazo has ... in various capacities with Prolong since 2007. He succeeds Prolong ... "I have known Glenn for more than thirty years," ... Mr. Kazo. "I feel he is one of the greatest ...
... 28 Tigris Pharmaceuticals, Inc., a ... it has completed a private placement of Series ... of approximately $6.5 million.  The financing, which was ... investors Wexford Spectrum Investors, LLC, and Sonostar Capital ...
Cached Medicine Technology:Prolong Pharmaceuticals Names Industry Veteran Glenn Kazo President 2Tigris Pharmaceuticals, Inc. Completes $6.5 Million Private Placement 2Tigris Pharmaceuticals, Inc. Completes $6.5 Million Private Placement 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: